Validation of an Allergic Rhinitis Control Test in Children aged 5 to 11 years

What this Trial Is About

Allergic rhinitis is a common condition affecting both adults and children, often leading to a reduced quality of life. Many patients feel unsatisfied with current treatments and seek better options to manage symptoms. While tools exist to assess control of allergic rhinitis, none have been validated for children under 12. This study aims to adapt and validate an allergic rhinitis control test for children aged 5 to 11 years old. The study involves children aged 5 to 11 who complete a self-administered questionnaire about their allergic rhinitis control during their consultation and again 15 days later. This questionnaire, originally validated for those aged 12 and older, is being adapted for the younger pediatric population. The intervention consists of this self-questionnaire to measure control of allergic rhinitis symptoms. Participants will complete the questionnaire twice, once at the consultation and once after 15 days, allowing researchers to measure the control of allergic rhinitis symptoms over time. The primary outcome is the score of this self-administered allergic rhinitis control questionnaire at 15 days. The study is observational without blinding or placebo, and participation lasts for at least 15 days from the initial visit to follow-up.

Validation of an Allergic Rhinitis Control Test in Children